Literature DB >> 1193824

Dane particles, DNA polymerase, and e-antigen in two different categories of hepatitis B antigen carriers.

E Nordenfelt, L Kjellén.   

Abstract

Two different categories of hepatitis B antigen carriers have been investigated. One comprises patients treated with dialysis and known to be highly infectious. The other consists of blood donors found in routine screenings. Serum specimens have been studied with regard to Dane particles. Dane-core-associated DNA polymerase activity, and e-antigen. The two groups differed markedly in the aspects studied. The five healthy blood donors had no, or very few, detectable Dane particles and no detectable DNA polymerase activity; four of the five healthy donors had antibodies against e-antigen. The one xickk donor and all six dialysis patients had many Dane particles and polymerase activity; five of the sick dialysis patients had e-antigen. Thus, these results further underline the difference between the two groups, and e-antigen and DNA polymerase activity could represent possible useful parameters for judging infectivity.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1193824     DOI: 10.1159/000149918

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  36 in total

1.  Hepatitis B antigen-associated deoxyribonucleic acid polymerase activity and e antigen/anti-e system.

Authors:  M Imai; F C Tachibana; Y Moritsugu; Y Miyakawa; M Mayumi
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

2.  Release of e antigen from a Dane particle-rich preparation of hepatitis B virus.

Authors:  K C Lam; M J Tong; J Rakela
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

3.  Solid-phase radioimmunoassay for hepatitis Be antigen (HBeAg).

Authors:  H E Blum; G Dölken; W Gerok
Journal:  Klin Wochenschr       Date:  1979-10-15

4.  Evidence for limited humoral immunoglobulin M antibody response to hepatitis B core antigen during acute and chronic hepatitis B virus infections.

Authors:  E G Lindenschmidt; C H Granato; K Kätzner; R Laufs
Journal:  J Clin Microbiol       Date:  1985-06       Impact factor: 5.948

5.  Hepatitis B e-antigen and its correlation with other serological markers in chimpanzees.

Authors:  C M Ling; I K Mushahwar; L R Overby; K R Berquist; J E Maynard
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

6.  Lack of supportive evidence for an autosomal recessive inheritance in chronic hepatitis B infections.

Authors:  M J Tong; J M Weiner
Journal:  Dig Dis Sci       Date:  1979-04       Impact factor: 3.199

7.  [Experiments for the development of a hepatitis B vaccine: immunogenicity of HBsAg in guinea pigs (author's transl)].

Authors:  B Stamm; W Gerlich; R Thomssen
Journal:  Med Microbiol Immunol       Date:  1979-05-15       Impact factor: 3.402

8.  e Antigen and antibody in outbreaks of hepatitis B in two renal dialysis units.

Authors:  P E Gibson
Journal:  J Clin Pathol       Date:  1977-08       Impact factor: 3.411

9.  Prevalence of specific markers of viral hepatitis A and B among an Ethiopian population.

Authors:  L Gebreselassie
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408

10.  [Spread of hepatitis B virus infection among family contacts of asymptomatic HBsAg carriers (author's transl)].

Authors:  H H Dormeyer; G Hess; M Born; H Schönborn; W Arnold; J Knolle; B Zöller
Journal:  Klin Wochenschr       Date:  1979-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.